Alfuzosin hydrochloride
- Level
- Commodity
- Parent
- 51263600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263603This classification denotes an alpha-adrenergic blocking agent with the molecular formula C19H27N5O4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 75046A1XTN, chemically known as 2-furancarboxamide, n-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-, monohydrochloride (+-)- but more generally known as alfuzosin hydrochloride, which bears US NIH Compound Identifier 71764. The base coompound, Alfuzosin, also comes in simple form. European Medicines Agency schedules Alfuzosin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00340MIG. Most nations, for tariff and trade purposes, schedule alfuzosin hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, ALFUZOSIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Alfuzosin hydrochloride bears US NLM identifiers UMLS ID C0102130 and NCI Concept Code C53408. SMILES: CN(CCCNC(=O)C1CCCO1)C2NC3CC(C(CC3C(N2)N)OC)OC.CL.
Same parent
Under 51263600 · 4Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.